- $17.97m
- -$43.23m
- CNY232.08m
- 58
- 69
- 43
- 57
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,074 | 835 | 482 | 337 | 232 |
Cost of Revenue | |||||
Gross Profit | 760 | 542 | 299 | 178 | 118 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,648 | 2,908 | 911 | 1,008 | 420 |
Operating Profit | -574 | -2,073 | -429 | -670 | -187 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -509 | -2,110 | -323 | -656 | -189 |
Provision for Income Taxes | |||||
Net Income After Taxes | -492 | -2,110 | -328 | -642 | -187 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -486 | -2,224 | -328 | -640 | -178 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,085 | -2,224 | -328 | -640 | -178 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -10.4 | -5.85 | -1.5 | -0.193 | -0.048 |